Polson Ltd vs Saroja Pharma Industries India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

The Latest Trading Price of Polson Ltd is ₹ 10550 as of 18 Mar 15:30 . The P/E Ratio of Polson Ltd changed from 12.9 on March 2021 to 27.5 on March 2025 . This represents a CAGR of 16.35% over 5 yearsThe P/E Ratio of Saroja Pharma Industries India Ltd changed from 16.1 on March 2024 to 14.7 on March 2025 . This represents a CAGR of -4.45% over 2 years The Market Cap of Polson Ltd changed from ₹ 110.07 crore on March 2021 to ₹ 143.88 crore on March 2025 . This represents a CAGR of 5.50% over 5 yearsThe Market Cap of Saroja Pharma Industries India Ltd changed from ₹ 14.11 crore on March 2024 to ₹ 15.18 crore on March 2025 . This represents a CAGR of 3.72% over 2 years The revenue of Polson Ltd for the Dec '25 is ₹ 22.57 crore as compare to the Sep '25 revenue of ₹ 22 crore. This represent the growth of 2.59% The revenue of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Polson Ltd for the Dec '25 is ₹ 4.14 crore as compare to the Sep '25 ebitda of ₹ 4 crore. This represent the growth of 3.5% The ebitda of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Polson Ltd changed from ₹ 1.43 crore to ₹ 1.21 crore over 7 quarters. This represents a CAGR of -9.10% The net profit of Saroja Pharma Industries India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Polson Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Polson Ltd

Incorporated in December, 1938 by Mr. Pestonji Edulgi, Polson Limited, primarily as a Coffee manufacturing Company, is presently engaged in manufacturing synthetic organic tanning substance.
The Company has diversified into other business activities including diary, agriculture, pharmaceuticals, leather chemicals and real estate.
With Government policy reserving the dairy sector for the Cooperative sector, the Company being a private organization was forced to end its dairy activities.
Their manufacturing units is located at Kolhapur in Maharashtra. With its manufacturing operations spread over 14 acres and located on the foothills of the historical fort Vishalgad, this Unit began its operations in 1906 by setting up the first and only Myrabolam Extracts manufacturing facility, primarily servicing the Indian Railway authorities by substituting an import.

About Saroja Pharma Industries India Ltd

Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.

FAQs for the comparison of Polson Ltd and Saroja Pharma Industries India Ltd

Which company has a larger market capitalization, Polson Ltd or Saroja Pharma Industries India Ltd?

Market cap of Polson Ltd is 125 Cr while Market cap of Saroja Pharma Industries India Ltd is 12 Cr

What are the key factors driving the stock performance of Polson Ltd and Saroja Pharma Industries India Ltd?

The stock performance of Polson Ltd and Saroja Pharma Industries India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Polson Ltd and Saroja Pharma Industries India Ltd?

As of March 18, 2026, the Polson Ltd stock price is INR ₹10470.65. On the other hand, Saroja Pharma Industries India Ltd stock price is INR ₹31.15.

How do dividend payouts of Polson Ltd and Saroja Pharma Industries India Ltd compare?

To compare the dividend payouts of Polson Ltd and Saroja Pharma Industries India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.